QA: AGILE THERAPEUTICS INC in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001261249_2020_AGILE_THERAPEUTICS_INC.pdf

Logs

info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001261249')"}

Graph

Absolute values for 0001261249, AGILE THERAPEUTICS INC

  xvar xval
0 AssetsCurrent 35,319,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 14,044,000
3 remainder_Assets 177,000
4 LiabilitiesCurrent 3,795,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 9,000,000
9 ResearchAndDevelopmentExpense 9,858,000
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 252,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 49,540,000
1 Liabilities 3,795,000
2 Expenses 18,858,000
3 Revenues 0
4 StockholdersEquity 45,745,000
5 NetIncome -18,606,000
6 ComprehensiveNetIncome -18,606,000
7 BaseVar 36,222,500
8 EconomicCapitalRatio 2.25

Edgar->Model Mapping

Feature Distribution

Change over Time